FRI0569-PC Pain, physical function and life quality evaluation in patients diagnosed of knee or hip ostroarthritis attended on the primary health care center of ciudades in getafe
Background Osteoarthritis (OA) is a well-known chronic degenerative pathology of multi-factorial etiology with an important impact on patients’ physical function. Studies such as EPISER and ArtroPro have related a keen drop on patients’ health-related quality of life with OA. OMERACT, OARSI and EULA...
Saved in:
Published in | Annals of the rheumatic diseases Vol. 72; no. Suppl 3; pp. A567 - A568 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BMJ Publishing Group Ltd and European League Against Rheumatism
01.06.2013
BMJ Publishing Group LTD |
Online Access | Get full text |
Cover
Loading…
Summary: | Background Osteoarthritis (OA) is a well-known chronic degenerative pathology of multi-factorial etiology with an important impact on patients’ physical function. Studies such as EPISER and ArtroPro have related a keen drop on patients’ health-related quality of life with OA. OMERACT, OARSI and EULAR experts have recommended the introduction of surveys which measure health-related quality of life, the degree of pain and physical function (SF-12, WOMAC) for a patient’s global evaluation. To standardize the use of such tools in everyday-practice allows assessing the global impact of this pathology over the patient’s quality of life. Objectives Describe the degree of pain, physical function and health-related quality of life in patients diagnosed of hip or/and knee OA. Methods A descriptive, transversal study was conducted in which patients diagnosed of knee or/and hip OA and registered attending the primary health consult. Heath-related quality of life was measured using SF-12 and WOMAC questionnaires; pain degree with the visual analgesic scale; and pharmacologic adhesion with the Morinsky Green scale. Results Out of 93 patients included in the study, 23 met exclusion criteria and 9 did not attend the consult. Age average of the 61 remaining patients was 67.83 years (49-84 years), 56.42% of which presented unilateral knee AO; while 70% presented bilateral hip affection. The most frequent clinical findings in knee OA were pain (75.61%), crepitus(75.61%) and stiffness (60.98%); while in hip OA was pain (80%), especially with internal rotation (60%). Most frequent analgesic treatment wasacetaminophen(58.54%), NSAIDs (43.9%) and mild opioids (26.83%). 31.71% practiced physical activities; 12.20% received health education and 12.20% was on diet. Hypertension (68.29%), anxiety/ depression (43.9%) and obesity (36.59%) were the most frequent comorbities found. EVA average resulted in 5.9 (DS 27.52). The most affected areas on the SF-12 v2 survey were physical activities (32.32%), general health (30.49%), physical role (41.46%) and social role (47,80%). On the WOMAC scale, pain average was 7.37 (DS 3.83), stiffness 2.61 (DS 2.06) and functional capacity 24.83 (DS 15.21). Appropriate treatment adherence was found on 41.46% of the patients. Conclusions A considerable decrease in OA patient’s life quality, including the physical and social spheres, is observed, with a substantial adding-up effect if there is more than one joint affected. However, the quality and amount of information found on the selected patients’ clinical history was not adequate. There is a need for standardization of the diagnostic criteria and of the degree of affection regarding the OA. References KM Jordan, et al:EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT).AnnRheumDis2003,62:1145-55. 6-P.G.Conaghan, et al.Summary and recommendations of the OARSI FDA osteoarthritis Assessment of Structural Change Working Group. Osteoarthritis and Cartilage19(2011)606e610. Vilagut G, et al.[Interpretation of SF-36 and SF-12 questionnaires in Spain: physical and mental components].MedClin(Barc).2008;130:726—35. Acknowledgements Alejandro Tejedor Varilla Juan Carlos Hermosa Hernan Disclosure of Interest None Declared |
---|---|
Bibliography: | href:annrheumdis-72-A567-4.pdf ark:/67375/NVC-B8FG14GN-Q local:annrheumdis;72/Suppl_3/A567-d ArticleID:annrheumdis-2013-eular.1696 istex:8A0D0DBFA04495CDBB1664A67562F982988FF018 |
ISSN: | 0003-4967 1468-2060 |
DOI: | 10.1136/annrheumdis-2013-eular.1696 |